Key points are not available for this paper at this time.
L-arginine adds no endothelial benefit in stable CAD on medical therapy; leaves open its utility in other CAD subsets or earlier disease stages.
a Department of Internal Medicine, Poriya Government Hospital, Lower Galilee, Israel and b Cardiology Branch, National Institutes of Health, Bethesda, Maryland, USA Correspondence and requests for reprints to Dr. Arnon Blum, Department of Internal Medicine, Poriya Government Hospital, Lower Galilee 15208, Israel. Tel: +972 6 6738333; fax: +972 6 6738439; e-mail: [email protected]
No takes yet. Share an insight, caveat, or question.
Blum et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: